Symbol="BHVN"
AssetType="Common Stock"
Name="Biohaven Pharmaceutical Holding Co Ltd"
Description="Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The company is headquartered in New Haven, Connecticut."
CIK="1935979"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="215 CHURCH STREET, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1383603000"
EBITDA="-420440992"
PERatio="None"
PEGRatio="None"
BookValue="5.67"
DividendPerShare="0"
DividendYield="0"
EPS="-7.96"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.877"
ReturnOnEquityTTM="-2.09"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-7.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="27.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="10.22"
EVToRevenue="-"
EVToEBITDA="-2.412"
Beta="None"
num_52WeekHigh="26.64"
num_52WeekLow="5.54"
num_50DayMovingAverage="22.52"
num_200DayMovingAverage="16.94"
SharesOutstanding="68225000"
DividendDate="None"
ExDividendDate="None"
symbol="BHVN"
open="19.43"
high="20.65"
low="19.25"
price="20.28"
volume="688386.00"
latest_trading_day="2023-08-08"
previous_close="19.23"
change="1.05"
change_percent="5.4602%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="1037631"
Change_recent_avg="0.06"
Delta_recent_avg="1.08"
Variance_recent_avg="0.54"
Change_ratio_recent_avg="0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="1150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0183.jpeg"
image_negative_thumbnail_id_2="105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="624"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_positive_thumbnail_id_2="706"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
